Indacaterol and glycopyrrolate Inhalation and Tafenoquine Succinate (Arakoda)
Determining the interaction of Indacaterol and glycopyrrolate Inhalation and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate / indacaterol
Brand name: Utibron Neohaler
Synonyms: Glycopyrrolate and indacaterol (inhalation), Indacaterol and Glycopyrrolate
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indacaterol and glycopyrrolate Inhalation-Tafenoquine Succinate (Krintafel)
- Indacaterol and glycopyrrolate Inhalation-Tafinlar
- Indacaterol and glycopyrrolate Inhalation-Tafluprost
- Indacaterol and glycopyrrolate Inhalation-Tafluprost ophthalmic
- Indacaterol and glycopyrrolate Inhalation-Tagamet
- Indacaterol and glycopyrrolate Inhalation-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Indacaterol inhalation
- Tafenoquine Succinate (Arakoda)-Indacaterol Maleate
- Tafenoquine Succinate (Arakoda)-Indapamide
- Tafenoquine Succinate (Arakoda)-Inderal
- Tafenoquine Succinate (Arakoda)-Inderal Intravenous
- Tafenoquine Succinate (Arakoda)-Inderal LA